Ray Asghari
Overview
Explore the profile of Ray Asghari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chantrill L, Nagrial A, Watson C, Johns A, Martyn-Smith M, Simpson S, et al.
Clin Cancer Res
. 2015 Apr;
21(9):2029-37.
PMID: 25896973
Purpose: Personalized medicine strategies using genomic profiling are particularly pertinent for pancreas cancer. The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) trial was initially designed to exploit results from genome sequencing...
12.
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables
Sze M, Butow P, Bell M, Vaccaro L, Dong S, Eisenbruch M, et al.
Oncologist
. 2015 Mar;
20(5):523-31.
PMID: 25802406
Background: Multiethnic societies face challenges in delivering evidence-based culturally competent health care. This study compared health-related quality of life and psychological morbidity in a hospital-based sample of first-generation migrants and...
13.
Chavada R, Keighley C, Quadri S, Asghari R, Hofmeyr A, Foo H
BMC Infect Dis
. 2014 Dec;
14:641.
PMID: 25466213
Background: Listeria monocytogenes causes gastroenteritis, meningitis and bacteraemia in immunocompromised, pregnant patients, the elderly as well in immunocompetent patients. Focal infections with this organism are uncommon, especially in sporadic (non-outbreak)...
14.
Jacob S, Ng W, Asghari R, Delaney G, Barton M
Clin Colorectal Cancer
. 2011 Aug;
10(2):102-7.
PMID: 21859561
Background: Published chemotherapy utilization rates for rectal cancer show considerable variation. Optimal chemotherapy utilization rates can serve as benchmarks to assess the quality of cancer care. The purpose of this...
15.
Jacob S, Ng W, Asghari R, Delaney G, Barton M
Eur J Cancer
. 2009 Jun;
45(14):2503-9.
PMID: 19527926
Background: Optimal chemotherapy (CT) utilisation rates can serve as benchmarks to assess the quality of cancer care. This study aims to determine the optimal proportion of patients with colon cancer...